'The University of Kentucky and University of Alabama, Birmingham, are partners on a $2.9 million, five-year National Institute on Aging clinical trial to explore how metformin may benefit older adults who do not respond well to exercise. Metformin, a generic drug and the most widely prescribed drug for type 2 diabetes, may be a low-cost, personalized approach to prevent frailty in the elderly by improving their muscle growth response.  Produced by Research Communications at the University of Kentucky' 

Tags: reveal , metformin , university of kentucky , Charlotte Peterson , Phil Kern , CCTS

See also: le , yoga for beginners , water jug fitness , army , abs workout , dds discount , deals , Detlef. , meal planning , work out

comments